Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Conclusions of the Drug Information Association (DIA)/European Medicines Agency (EMEA) Workshop, October 27-28, 2003 in London, UK

Author： Peter Kasper  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.18, Iss.4, 2004-01, pp. : 221-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Case Reports

By Bernard Leblanc  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 215-220

Adis International

Access to resources Recommend Favorite

Assessment and Acceptance of Thresholds of Genotoxic Impurities in New Drug Substances: A Regulatory Perspective

By Peter Kasper  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 209-214

Adis International

Access to resources Recommend Favorite

Setting Limits for Genotoxic Impurities in Drug Substances: Threshold-Based and Pragmatic Approaches

By David Kirkland  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 197-207

Adis International

Access to resources Recommend Favorite

The European Medicines Evaluation Agency: role of experts in drug assessment

By Benzi G.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 12, 1995-12 ,pp. : 409-412

Elsevier

Access to resources Recommend Favorite

Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years

By Ceci A.   Felisi M.   Baiardi P.   Bonifazi F.   Catapano M.   Giaquinto C.   Nicolosi A.   Sturkenboom M.   Neubert A.   Wong I.  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 947-952

Springer Publishing Company

Access to resources Recommend Favorite